Detailed information for compound 947045

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 329.354 | Formula: C16H19N5O3
  • H donors: 3 H acceptors: 2 LogP: -0.35 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1NN=C2N(C1)c1cc(ccc1OC2)NC(=O)C1CCNCC1
  • InChi: 1S/C16H19N5O3/c22-15-8-21-12-7-11(18-16(23)10-3-5-17-6-4-10)1-2-13(12)24-9-14(21)19-20-15/h1-2,7,10,17H,3-6,8-9H2,(H,18,23)(H,20,22)
  • InChiKey: IANOBBKWTOMOAJ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens protein kinase C, theta Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Onchocerca volvulus Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis expressed protein 0.0106 0.5565 1
Schistosoma mansoni serine/threonine protein kinase 0.0022 0.0563 0.0985
Entamoeba histolytica peptidyl-prolyl cis-trans isomerase, putative 0.0103 0.5416 1
Trichomonas vaginalis rotamase, putative 0.0103 0.5416 0.9732
Trypanosoma brucei peptidyl-prolyl cis-trans isomerase, putative 0.0032 0.1166 0.2128
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Schistosoma mansoni serine/threonine protein kinase 0.0022 0.0563 0.0985
Echinococcus granulosus expressed protein 0.0106 0.5565 1
Loa Loa (eye worm) hypothetical protein 0.0176 0.9774 0.9773
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Echinococcus granulosus protein kinase c iota type 0.0022 0.0563 0.0985
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Schistosoma mansoni atypical protein kinase C 0.0022 0.0563 0.0985
Trichomonas vaginalis conserved hypothetical protein 0.0106 0.5565 1
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Trypanosoma brucei peptidyl-prolyl cis-trans isomerase/rotamase, putative 0.0103 0.5416 1
Brugia malayi protein kinase C II. 0.0022 0.0563 0.0985
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Loa Loa (eye worm) Pin1-type peptidyl-prolyl cis-trans isomerase 0.0106 0.5565 0.5557
Trypanosoma cruzi peptidyl-prolyl cis-trans isomerase 0.0103 0.5416 1
Schistosoma mansoni serine/threonine protein kinase 0.0022 0.0563 0.0985
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Loa Loa (eye worm) hypothetical protein 0.0167 0.9227 0.9226
Onchocerca volvulus 0.0167 0.9227 0.5
Brugia malayi Pin1-type peptidyl-prolyl cis-trans isomerase, BmPin1 0.0106 0.5565 1
Toxoplasma gondii peptidylprolyl isomerase 0.0103 0.5416 1
Schistosoma mansoni rotamase 0.0106 0.5565 1
Loa Loa (eye worm) AGC/PKC/ETA protein kinase 0.0022 0.0563 0.0547
Echinococcus granulosus Protein kinase C brain isozyme 0.0022 0.0563 0.0985
Echinococcus multilocularis protein kinase c epsilon type 0.0022 0.0563 0.0985
Loa Loa (eye worm) hypothetical protein 0.0167 0.9227 0.9226
Loa Loa (eye worm) hypothetical protein 0.0167 0.9227 0.9226
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Trypanosoma cruzi peptidyl-prolyl cis-trans isomerase 0.0103 0.5416 1
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Echinococcus multilocularis protein kinase c iota type 0.0022 0.0563 0.0985
Trichomonas vaginalis rotamase, putative 0.0106 0.5565 1
Echinococcus granulosus protein kinase c epsilon type 0.0022 0.0563 0.0985
Toxoplasma gondii PPIC-type PPIASE domain-containing protein 0.0032 0.1166 0.2128
Wolbachia endosymbiont of Brugia malayi parvulin-like peptidyl-prolyl isomerase, PPID 0.0032 0.1166 0.5
Trichomonas vaginalis AGC family protein kinase 0.0013 0.0017 0.003
Leishmania major peptidyl-prolyl cis-trans isomerase/rotamase, putative,PPIase, putative 0.0103 0.5416 1
Echinococcus multilocularis Protein kinase C, brain isozyme 0.0022 0.0563 0.0985

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3.5 uM Inhibition of human recombinant PKCtheta expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay ChEMBL. 25000588

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.